I know from experience that Rituximab was recommended by one of the Renal doctors. But also know it is not for everyone.
It's good to get some opposing view to challenge the thesis. I don't know why everyone so sensitive about this.
I see Rituximab as the cheaper and more affordable option before people look at the Dimerix offering.
Ann: Investor Presentation, page-100
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
45.5¢ |
Change
0.055(13.8%) |
Mkt cap ! $250.1M | |||
| Open | High | Low | Value | Volume |
| 40.5¢ | 47.0¢ | 40.3¢ | $5.392M | 12.10M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14351 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.0¢ | 28878 | 5 |
View Market Depth
| Last trade - 16.10pm 30/05/2024 (20 minute delay) ? |
|
|||||
|
Last
45.3¢ |
Change
0.055 ( 13.1 %) |
||||
| Open | High | Low | Volume | ||
| 40.5¢ | 47.0¢ | 40.0¢ | 7666660 | ||
| Last updated 15.59pm 30/05/2024 ? | |||||
| DXB (ASX) Chart |